These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1518 related articles for article (PubMed ID: 19483106)

  • 41. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
    Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver.
    Sanderson LM; Degenhardt T; Koppen A; Kalkhoven E; Desvergne B; Müller M; Kersten S
    Mol Cell Biol; 2009 Dec; 29(23):6257-67. PubMed ID: 19805517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts.
    Zhang H; Pi R; Li R; Wang P; Tang F; Zhou S; Gao J; Jiang J; Chen S; Liu P
    Arch Biochem Biophys; 2007 Apr; 460(1):25-32. PubMed ID: 17346664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PPAR agonists modulate human osteoclast formation and activity in vitro.
    Chan BY; Gartland A; Wilson PJ; Buckley KA; Dillon JP; Fraser WD; Gallagher JA
    Bone; 2007 Jan; 40(1):149-59. PubMed ID: 17010686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver.
    Sanderson LM; Boekschoten MV; Desvergne B; Müller M; Kersten S
    Physiol Genomics; 2010 Mar; 41(1):42-52. PubMed ID: 20009009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
    Shioi R; Okazaki S; Noguchi-Yachide T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3131-3134. PubMed ID: 28539218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors.
    Nijsten T; Geluyckens E; Colpaert C; Lambert J
    J Cutan Pathol; 2005 May; 32(5):340-7. PubMed ID: 15811118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures.
    Cristiano L; Cimini A; Moreno S; Ragnelli AM; Paola Cerù M
    Neuroscience; 2005; 131(3):577-87. PubMed ID: 15730864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes.
    Poleni PE; Bianchi A; Etienne S; Koufany M; Sebillaud S; Netter P; Terlain B; Jouzeau JY
    Osteoarthritis Cartilage; 2007 May; 15(5):493-505. PubMed ID: 17140817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
    Takada I; Makishima M
    Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
    [No Abstract]   [Full Text] [Related]  

  • 54. Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
    Chopra B; Georgopoulos NT; Nicholl A; Hinley J; Oleksiewicz MB; Southgate J
    Cell Prolif; 2009 Oct; 42(5):688-700. PubMed ID: 19614673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.
    Gaspar JC; Okine BN; Llorente-Berzal A; Roche M; Finn DP
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32102354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation.
    Smith SG; Hill M; Oliveria JP; Watson BM; Baatjes AJ; Dua B; Howie K; Campbell H; Watson RM; Sehmi R; Gauvreau GM
    Immunology; 2014 Jul; 142(3):484-91. PubMed ID: 24628018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications.
    Benetti E; Patel NS; Collino M
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):273-84. PubMed ID: 21696362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism.
    Roche E; Lascombe I; Bittard H; Mougin C; Fauconnet S
    Cell Signal; 2014 Feb; 26(2):433-43. PubMed ID: 24172859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro interaction between resistin and peroxisome proliferator-activated receptor γ in porcine ovarian follicles.
    Rak-Mardyła A; Drwal E
    Reprod Fertil Dev; 2016 Mar; 28(3):357-68. PubMed ID: 25034013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.